XLRN
Acceleron Pharma
XLRN
XLRN
Delisted
XLRN was delisted on the 19th of November, 2021.
111 hedge funds and large institutions have $607M invested in Acceleron Pharma in 2015 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 46 increasing their positions, 31 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
40% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 15
67% less call options, than puts
Call options by funds: $1.8M | Put options by funds: $5.49M
Holders
111
Holding in Top 10
4
Calls
$1.8M
Puts
$5.49M
Top Buyers
| 1 | +$9.32M | |
| 2 | +$4.17M | |
| 3 | +$3.74M | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$3.04M |
| 5 |
ORI
Oak Ridge Investments
Chicago,
Illinois
|
+$2.99M |
Top Sellers
| 1 | -$10.1M | |
| 2 | -$8.37M | |
| 3 | -$6.37M | |
| 4 |
PCM
Pentwater Capital Management
Naples,
Florida
|
-$2.87M |
| 5 |
WSA
Wall Street Associates
Lajolla,
California
|
-$2.4M |